R. Lyu

969 total citations
15 papers, 719 citations indexed

About

R. Lyu is a scholar working on Rheumatology, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, R. Lyu has authored 15 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Epidemiology. Recurrent topics in R. Lyu's work include Rheumatoid Arthritis Research and Therapies (8 papers), Spondyloarthritis Studies and Treatments (4 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). R. Lyu is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (8 papers), Spondyloarthritis Studies and Treatments (4 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). R. Lyu collaborates with scholars based in United States, Sweden and China. R. Lyu's co-authors include D. Yin, Girishanthy Krishnarajah, Panagiotis Mavros, Lip Ping Low, Fernando Álvarez Guisasola, Paul Nestel, Ikuo Saito, Wannee Nitiyanant, Chee Eng Tan and Santiago Tofé and has published in prestigious journals such as Diabetes Care, Diabetologia and Annals of the Rheumatic Diseases.

In The Last Decade

R. Lyu

14 papers receiving 702 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Lyu United States 8 436 136 86 70 63 15 719
Sun-Hye Ko South Korea 14 263 0.6× 105 0.8× 104 1.2× 51 0.7× 35 0.6× 37 619
Anat Fisher Canada 11 186 0.4× 55 0.4× 57 0.7× 53 0.8× 35 0.6× 32 451
Kunal Kothari India 9 372 0.9× 242 1.8× 43 0.5× 77 1.1× 45 0.7× 15 644
Shuxia Guo China 14 168 0.4× 154 1.1× 29 0.3× 116 1.7× 28 0.4× 55 481
Hiroaki Ikezaki Japan 18 351 0.8× 269 2.0× 28 0.3× 151 2.2× 54 0.9× 56 882
Letícia Schwerz Weinert Brazil 17 176 0.4× 67 0.5× 24 0.3× 68 1.0× 111 1.8× 40 699
Jia‐Jung Lee Taiwan 14 145 0.3× 257 1.9× 24 0.3× 102 1.5× 29 0.5× 45 780
Ravinder Garg India 13 102 0.2× 155 1.1× 46 0.5× 37 0.5× 31 0.5× 48 522
Soraya Fellahi France 17 64 0.1× 184 1.4× 125 1.5× 32 0.5× 27 0.4× 34 774
Mireia Junyent Spain 18 229 0.5× 103 0.8× 50 0.6× 389 5.6× 91 1.4× 37 971

Countries citing papers authored by R. Lyu

Since Specialization
Citations

This map shows the geographic impact of R. Lyu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Lyu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Lyu more than expected).

Fields of papers citing papers by R. Lyu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Lyu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Lyu. The network helps show where R. Lyu may publish in the future.

Co-authorship network of co-authors of R. Lyu

This figure shows the co-authorship network connecting the top 25 collaborators of R. Lyu. A scholar is included among the top collaborators of R. Lyu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Lyu. R. Lyu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Dalén, Johan, Axel Svedbom, Christopher M. Black, et al.. (2016). Treatment persistence among patients with immune-mediated rheumatic disease newly treated with subcutaneous TNF-alpha inhibitors and costs associated with non-persistence. Rheumatology International. 36(7). 987–995. 50 indexed citations
3.
Lyu, R., Qian Ding, Christopher M. Black, et al.. (2015). Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany. Rheumatology International. 36(1). 143–153. 23 indexed citations
4.
Dalén, Johan, et al.. (2015). THU0370 Treatment Persistence Among Patients with Rheumatoid Disease (RD) Newly Treated with Subcutaneous TNF-Alpha Blockers. Annals of the Rheumatic Diseases. 74. 330–330. 1 indexed citations
5.
Govoni, Marcello, R. Lyu, Qian Ding, & Tao Fan. (2014). Persistence Rate With Subcutaneous Biologic Therapies in Patients With Ankylosing Spondylitis (As). Value in Health. 17(7). A384–A384. 2 indexed citations
6.
Lyu, R., et al.. (2014). Treatment Persistence With Subcutaneous Biologic Therapies in Patients With Psoriatic Arthritis (Psa). Value in Health. 17(7). A384–A385. 1 indexed citations
7.
Lyu, R., Marcello Govoni, Qian Ding, et al.. (2014). AB1091 Treatment Persistence with Subcutaneous Biologic Therapies in Patients with Rheumatoid Arthritis. Annals of the Rheumatic Diseases. 73. 1162–1163. 1 indexed citations
8.
Combe, Bernard, Douglas J. Veale, Rubén Burgos‐Vargas, et al.. (2014). AB0373 Integrating Treatment Goals of Physicians, Patients, and Payers during Treatment with Golimumab in Patients with Rheumatoid Arthritis. Annals of the Rheumatic Diseases. 73. 928–928.
9.
Govoni, Marcello, R. Lyu, Qian Ding, et al.. (2014). AB1077 Treatment Patterns and Persistence with Subcutaneous Biologic Therapies in Patients with Ankylosing Spondylitis. Annals of the Rheumatic Diseases. 73. 1157–1157. 5 indexed citations
10.
Vexiau, P, Panagiotis Mavros, Girishanthy Krishnarajah, R. Lyu, & D. Yin. (2008). Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France. Diabetes Obesity and Metabolism. 10(s1). 16–24. 96 indexed citations
11.
12.
Nestel, Paul, R. Lyu, Lip Ping Low, et al.. (2007). Metabolic syndrome: recent prevalence in East and Southeast Asian populations.. PubMed. 16(2). 362–7. 186 indexed citations
13.
Yang, Xilin, Wing‐Yee So, Alice P.S. Kong, et al.. (2006). End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes Registry. Diabetologia. 49(10). 2299–2308. 62 indexed citations
14.
Yang, Xilin, Wing‐Yee So, Alice P.S. Kong, et al.. (2006). Development and Validation of Stroke Risk Equation for Hong Kong Chinese Patients With Type 2 Diabetes. Diabetes Care. 30(1). 65–70. 96 indexed citations
15.
Tramarin, Andrea, Stefano Campostrini, Donald Yin, et al.. (2004). Association between diarrhea and quality of life in HIV-infected patients receiving highly active antiretroviral therapy. Quality of Life Research. 13(1). 243–250. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sun-Hye Ko Breakdown of academic impact, for papers by Anat Fisher Breakdown of academic impact, for papers by Kunal Kothari Breakdown of academic impact, for papers by Shuxia Guo Breakdown of academic impact, for papers by Hiroaki Ikezaki Breakdown of academic impact, for papers by Letícia Schwerz Weinert Breakdown of academic impact, for papers by Jia‐Jung Lee Breakdown of academic impact, for papers by Ravinder Garg Breakdown of academic impact, for papers by Soraya Fellahi Breakdown of academic impact, for papers by Mireia Junyent
Rankless by CCL
2026